Evidence map›Paper›PMID 41502902›Full record

ArticleTranslational pediatrics2025

Analysis of the therapeutic effect of allogeneic hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia with

Yuanfang Jing, Ang Wei, Chenguang Jia, Jun Yang, Guanghua Zhu, Yanhui Luo, Kaige Zhang, Wei Yang, Wei Chen, Meng Zhang and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuanfang Jing *Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Ang Wei *Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Chenguang JiaBeijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Jun YangBeijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Guanghua ZhuBeijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Yanhui LuoBeijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Kaige ZhangBeijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Wei YangBeijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Wei ChenBeijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Meng ZhangBeijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Maoquan QinBeijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Bin WangBeijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics (Capital Medical University), Key Laboratory of Major Diseases in Children, Ministry of Education, Department of Stem cell Transplantation, Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The fusion gene Case Description: In this case series, we review the clinical course of 4 pediatric patients with Conclusions: The combination of CAR-T-cell therapy before HSCT and pro-DLI treatment after HSCT may represent an effective strategy to improve outcomes in these pediatric patients.

Indexed as

Acute lymphoblastic leukemia (ALL)case seriesE2A::HLFhematopoietic stem cell transplantation (HSCT)pediatric

Identifiers

PMID41502902
PMCPMC12771198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.